Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendat...

por Vysotskaia, Valentina, Kaseniit, K. Eerik, Bucheit, Leslie, Ready, Kaylene, Price, Kristin, Johansen Taber, Katherine
Publicado 2019

Design and validation of a next generation sequencing assay for hereditary BRCA1 and BRCA2 mutation testing

por Kang, Hyunseok P., Maguire, Jared R., Chu, Clement S., Haque, Imran S., Lai, Henry, Mar-Heyming, Rebecca, Ready, Kaylene, Vysotskaia, Valentina S., Evans, Eric A.
Publicado 2016

Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform

por Kidess, Evelyn, Heirich, Kyra, Wiggin, Matthew, Vysotskaia, Valentina, Visser, Brendan C., Marziali, Andre, Wiedenmann, Bertram, Norton, Jeffrey A., Lee, Mark, Jeffrey, Stefanie S., Poultsides, George A.
Publicado 2014

Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer

por Kidess-Sigal, Evelyn, Liu, Haiyan E., Triboulet, Melanie M., Che, James, Ramani, Vishnu C., Visser, Brendan C., Poultsides, George A., Longacre, Teri A., Marziali, Andre, Vysotskaia, Valentina, Wiggin, Matthew, Heirich, Kyra, Hanft, Violet, Keilholz, Ulrich, Tinhofer, Ingeborg, Norton, Jeffrey A., Lee, Mark, Sollier-Christen, Elodie, Jeffrey, Stefanie S.
Publicado 2016

Development and validation of a 36-gene sequencing assay for hereditary cancer risk assessment

por Vysotskaia, Valentina S., Hogan, Gregory J., Gould, Genevieve M., Wang, Xin, Robertson, Alex D., Haas, Kevin R., Theilmann, Mark R., Spurka, Lindsay, Grauman, Peter V., Lai, Henry H., Jeon, Diana, Haliburton, Genevieve, Leggett, Matt, Chu, Clement S., Iori, Kevin, Maguire, Jared R., Ready, Kaylene, Evans, Eric A., Kang, Hyunseok P., Haque, Imran S.
Publicado 2017